The endothelium plays a critical role in vascular homeostasis and response to injury. Work contributed by our laboratory during the previous funding term characterized the role of endothelial cells (EC) in novel inflammatory and procoagulant mechanisms. These studies also identified a novel anti-apoptosis molecule of the IAP gene family, designated survivin. Expressed in embryonic and fetal development, survivin is undetectable' in quiescent normal tissues and becomes abundantly re-expressed in all common human cancers, in vivo. Recently, we found that survivin is the first apoptosis inhibitor to date to be expressed in mitosis (02/M) in a cell cycle-dependent manner, and to localize to mitotic spindle microtubules of dividing cells. Moreover, growth factor stimulation of EC resulted in prominent expression of survivin during angiogenic responses, in vitro and in vivo. Therefore, the hypothesis that cell cycle expression of survivin may counteract apoptosis of proliferating EC during angiogenesis can be hypothesized, and will constitute the focus of this continuation application. In the first specific aim, we will characterize the spectrum of cytoprotection mediated by survivin in proliferating EC, in vitro and in vivo, and determine the effect of survivin targeting in models of angiogenesis. In the second specific aim, we will characterize the structure-function relationship of survivin- microtubule interaction and its cellular and molecular requirements for apoptosis inhibition in dividing EC. In the third specific aim, we will dissect the growth factor signaling pathway leading to survivin gene expression and identify mediators linking the control of EC proliferation to apoptosis inhibition. In continuity with the broad objectives the overall proposal is designed to elucidate a novel interface between EC proliferation and survival. These studies should provide important; insights for therapeutic manipulation of EC apoptosis during normal or aberrant (tumor) angiogenesis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL054131-06
Application #
6011501
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Project Start
1994-08-01
Project End
2004-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Yale University
Department
Pathology
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Chae, Young Chan; Angelin, Alessia; Lisanti, Sofia et al. (2013) Landscape of the mitochondrial Hsp90 metabolome in tumours. Nat Commun 4:2139
Vaira, Valentina; Faversani, Alice; Martin, Nina M et al. (2013) Regulation of lung cancer metastasis by Klf4-Numb-like signaling. Cancer Res 73:2695-705
Altieri, Dario C (2013) Targeting survivin in cancer. Cancer Lett 332:225-8
Caino, M Cecilia; Chae, Young Chan; Vaira, Valentina et al. (2013) Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells. J Clin Invest 123:2907-20
Chae, Young Chan; Caino, M Cecilia; Lisanti, Sofia et al. (2012) Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s. Cancer Cell 22:331-44
Yu, Jun; Zhang, Yuanyuan; Zhang, Xinbo et al. (2012) Endothelium derived nitric oxide synthase negatively regulates the PDGF-survivin pathway during flow-dependent vascular remodeling. PLoS One 7:e31495
Vaira, V; Faversani, A; Dohi, T et al. (2012) miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression. Oncogene 31:27-38
Kang, Byoung Heon; Xia, Fang; Pop, Ramona et al. (2011) Developmental control of apoptosis by the immunophilin aryl hydrocarbon receptor-interacting protein (AIP) involves mitochondrial import of the survivin protein. J Biol Chem 286:16758-67
Siegelin, Markus D; Dohi, Takehiko; Raskett, Christopher M et al. (2011) Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. J Clin Invest 121:1349-60
Altieri, Dario C (2011) Mitochondrial compartmentalized protein folding and tumor cell survival. Oncotarget 2:347-51

Showing the most recent 10 out of 108 publications